Benefits
Improved Exercise Performance
Raises muscle carnosine, which buffers the hydrogen ions that build up during hard efforts and delays the point where pace or power drops off. The benefit sits in continuous high-intensity work lasting roughly one to ten minutes, such as an 800 to 1500 meter run, a rowing piece or a hard cycling interval. It is not a single-sprint or single-set aid: a meta-analysis of 15 trials in 360 participants found no significant benefit for efforts under 60 seconds (P=0.312). The effect is also small where it exists: an overall improvement of 2.85% in that analysis, and an effect size of 0.18 across 1,461 participants in the largest meta-analysis to date. Typical doses are 4 to 6 g per day for at least 4 weeks.
Muscle Strength: Not Established
None of the references listed on this page measured maximal strength. The ISSN position stand and the meta-analyses all assess exercise capacity, not one-rep-max strength. One small 30-person trial reported a bench press benefit, but it is not among the references listed below and stands alone. Any effect on lifting is most likely indirect, through sustaining output across longer or repeated sets.
Reduced Muscle Fatigue
Helps maintain muscle pH, reducing the "burn" during intense exercise, especially in anaerobic conditions.
Longer Efforts, Not Aerobic Capacity
Efforts longer than 240 seconds did improve in the 15-trial meta-analysis, though the statistical signal there (P=0.046) was weaker than in the 60 to 240 second range (P=0.001). A 2024 meta-analysis of 18 trials in 331 trained males found its largest effect in tasks lasting 4 to 10 minutes, effect size 0.55. No cited study measured VO2 max, so this is exercise capacity rather than aerobic capacity in the strict sense.
Cognitive Effects: No Evidence Cited Here
No study cited on this page examined cognition. Carnosine is present in nerve tissue and has been studied in animals, but there is no human evidence on this page to support a cognitive claim. Treat it as an open research question, not a reason to buy.
Mechanism of action
Carnosine Synthesis
In muscle cells, beta-alanine combines with L-histidine to form carnosine, catalyzed by the enzyme carnosine synthase. Beta-alanine is the rate-limiting precursor, meaning its availability primarily determines carnosine production.
Buffering Hydrogen Ions
Carnosine acts as an intramuscular buffer, neutralizing hydrogen ions (H⁺) that accumulate during high-intensity exercise. This slows the fall in muscle pH during hard work, which delays fatigue and helps sustain performance in efforts lasting roughly one to ten minutes.
Performance Benefits
By increasing carnosine levels, beta-alanine supplementation improves exercise capacity in continuous high-intensity efforts of roughly one to ten minutes. No study cited here measured maximal strength, and the pooled trial data found no significant benefit for efforts under 60 seconds (P=0.312). Typical doses are 4–6 g/day, taken over weeks to significantly elevate muscle carnosine.
Clinical trials
Pooled analysis of 15 randomized, double-blind, placebo-controlled trials examining beta-alanine supplementation on exercise performance in healthy adults. Studies used 1.6-6.4 g/day for 4-12 weeks. 360 participants in total, 174 on beta-alanine and 186 on placebo, across 23 exercise tests. (Hobson et al. 2012, Amino Acids, PMID 22270875)
Pooled across 15 clinical trials.
Beta-alanine improved exercise capacity vs placebo: median effect size 0.374 against 0.108 for placebo (p=0.002), an overall improvement of 2.85%. By duration, the picture is specific: no significant benefit under 60 seconds (P=0.312), a clear benefit at 60-240 seconds (P=0.001), and a weaker but still significant benefit above 240 seconds (P=0.046). Mechanism: increased muscle carnosine buffers H+ during high-intensity exercise. Effects emerge after 2-4 weeks of loading.
Systematic risk assessment and pooled analysis of 101 human and 50 animal studies evaluating safety of oral beta-alanine. Outcomes: paresthesia, biomarker changes, adverse events, taurine status. (Dolan et al. 2019, Adv Nutr, PMID 30980076)
Pooled human studies (101) plus animal models (50).
Paresthesia (tingling) was the only side effect reported across that literature, with an odds ratio of 8.9 versus placebo (95% CrI 2.2 to 32.6). It is dose-dependent and largely avoided with sustained-release formulations or split doses. No effect on skeletal muscle taurine (effect size 0.156, 95% CrI -0.38 to 0.72). No serious adverse events. The authors concluded that beta-alanine, within the doses used in the available research designs, does not adversely affect those consuming it.
Evidence review of 18 randomized, double-blind, placebo-controlled trials with 331 trained males (18-40 years) examining beta-alanine on maximal-intensity exercise performance. (2024, Int J Sport Nutr Exerc Metab, PMID 39032921)
331 trained males across 18 clinical trials.
Beta-alanine improved performance overall, effect size 0.39 (95% CI 0.09 to 0.69, p=.01), which is a small effect. The largest effect was in tasks lasting 4 to 10 minutes, effect size 0.55 (95% CI 0.07 to 1.04, p=.03), not in sprints. All 331 participants were trained males aged 18 to 40, so the result has not been shown to apply to women, untrained people or older adults.
Randomized, double-blind, placebo-controlled trial in 16 physically active subjects (8 per group) receiving 5 g/day beta-alanine or placebo for 4 weeks. Outcomes: 10-km running time-trial performance. (Front Nutr. This trial is not among the references listed below, so a reader cannot verify it from this page.)
16 physically active subjects. 4-week intervention.
The beta-alanine group improved 10-km running time compared with placebo. With 8 people per arm this is a very small trial and the absolute improvement was modest, so the result can turn on one or two runners. Treat it as a single data point, not as established evidence for endurance running.
Randomized, double-blind, placebo-controlled trial in 30 strength-trained participants randomized to 6.4 g/day beta-alanine (8 × 800 mg sustained-release) or placebo during a 5-week strength training program. (Maté-Muñoz et al. 2018, J Int Soc Sports Nutr. Not among the references listed below.)
30 strength-trained adults. 5-week intervention.
The beta-alanine group showed greater improvement in bench press and total volume lifted than placebo. This is one 30-person trial, roughly 15 per arm. None of the meta-analyses cited on this page assessed maximal strength, so this result stands alone and should not be read as settled.
Randomized, double-blind, placebo-controlled trial in 19 men (10 beta-alanine, 9 placebo) receiving 15 g/day sustained-release beta-alanine for 8 weeks. Comprehensive safety panel: hematology, biochemistry, taurine, kidney/liver function. (2023, Front Nutr. Not among the references listed below.)
19 healthy men. 8-week high-dose safety study.
At 15 g/day, roughly 3 to 4 times the typical dose, there were no clinically significant changes in laboratory parameters, taurine status, or liver and kidney function, and no serious adverse events. With 10 men on beta-alanine and 9 on placebo for 8 weeks, a study this small can only rule out common and obvious problems. The broader safety picture comes from the 101-study risk assessment above.